Frank Feng, DO
Orthopaedic Surgery · Visalia, CANPI 1730281254
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,076 of the $61,474 with a category attached, or 66.8%. 13 manufacturers reported payments, led by Sequoia Surgical Distributors, LLC at 53.6% of the total. Reporting peaked in 2019 at $19,345 and has fallen 72.5% since, to $5,329 in 2025.
Across 57 payments — averaging $1078.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sequoia Surgical Distributors, LLC$33K
- Globus Medical$18K
- Medtronic$10K
- Innovasis Inc$350
- Alphatec Spine, Inc$127
- Intrinsic Therapeutics$127
- plus $365 from 7 others
Across 8 payments — averaging $36,550 each. An ownership or investment interest held by the physician or an immediate family member.
- Sequoia Surgical Distributors, LLC$292K
- Renovis Surgical Technologies, Inc.$0
What the payments were for
- Royalty or licence$17,87729%
- Speaking & faculty fees$41,07667%
- Travel & lodging$1,1012%
- Food & beverage$1,4202%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sequoia Surgical Distributors, LLC | 7 | $32,976 |
| Globus Medical(2 entities) | 20 | $17,980 |
| Medtronic(2 entities) | 15 | $9,549 |
| Innovasis Inc | 2 | $350 |
| Alphatec Spine, Inc | 1 | $127 |
| Intrinsic Therapeutics | 1 | $127 |
| Stryker | 2 | $111 |
| Merck | 1 | $97 |
| Vertex | 3 | $55 |
| Smith+Nephew | 2 | $36 |
| Boston Scientific | 1 | $31 |
| Davol Inc. | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Armada$17,877
- INTELLIS$9,075
- Barricaid Annular Closure Device$127
How this compares
$61,474 in reported general payments places this provider in the 85th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 231 | $2,609 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $163 |
| Tramadol Hcl | 61 | $161 |
| Gabapentin | 14 | $134 |
| Pregabalin | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Visalia
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.